Project documents | Vemurafenib for treating resected BRAF V600 mutation-positive melanoma [ID1250] | Guidance | NICE

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 314 KB)

Published:

05 September 2017
Draft matrix post referral (PDF 259 KB)

Published:

05 September 2017

Draft scope documents

Draft scope and provisional matrix comments table (post-referral) (PDF 314 KB)

Published:

12 September 2017
Provisional matrix (post-referral) (PDF 259 KB)

Published:

12 September 2017